If so, then this might be game over and millions of shares will hit the market. I do not think the registration of Pepin's shares has anything to do with the strategy. Every investor would want to have his holdings registered at one point. Some might sell now on frustration that Oxycyte is not playing a major part in the companies strategy, (as it appears from todays call). Patient enrollment in phase 3 might give a boost and if results and good data will follow the stock price has a great potential from here...
News 
Market Data 
Discover 
